loader2
NRI

Feb 12, 2025

loader2

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 46.40 10.54 0.06 41.00 0.03 44.71 34.88
Cipla Ltd 23.51 4.55 0.24 18.56 0.03 22.27 16.58
J B Chemicals & Pharmaceuticals Ltd 39.18 7.20 0.13 31.64 0.18 24.90 20.45
Dr Reddys Laboratories Ltd 18.83 3.61 0.30 13.36 0.06 26.59 21.64
Lupin Ltd 35.91 4.71 0.17 27.54 0.28 15.34 14.47
Torrent Pharmaceuticals Ltd 56.43 9.80 0.07 36.36 0.72 23.21 25.38
Ipca Laboratories Ltd 53.61 4.67 0.19 36.63 0.24 12.92 8.69
Sun Pharmaceuticals Industries Ltd 34.58 8.41 0.17 30.04 0.08 17.20 16.13
Aurobindo Pharma Ltd 18.89 2.32 0.46 12.87 0.21 13.51 11.18
Natco Pharma Ltd 11.43 5.56 0.32 11.87 0.05 29.63 25.88
Granules India Ltd 27.90 2.97 0.26 20.68 0.40 15.22 13.38
Ajanta Pharma Ltd 35.11 7.49 0.12 27.06 0.01 31.59 23.47
Gland Pharma Ltd 33.89 4.21 0.37 15.52 0.02 13.44 9.26
Biocon Ltd 56.19 2.94 0.48 24.52 0.91 6.35 6.89
Alkem Laboratories Ltd 26.06 4.45 0.20 23.88 0.15 18.29 18.72
Glenmark Pharmaceuticals Ltd 0.00 3.47 0.21 0.00 0.34 12.05 -50.87
Zydus Lifesciences Ltd 20.90 4.85 0.23 16.80 0.05 23.94 20.64
Divis Laboratories Ltd 76.41 20.13 0.09 75.14 0.00 16.41 12.15
Mankind Pharma Ltd 49.54 9.79 0.13 40.43 0.02 27.91 23.12
Laurus Labs Ltd 163.88 6.50 0.13 50.21 0.56 6.31 4.13

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 60826.50
(-0.0021%)
77918.0 55701.90
Nifty Bank 49479.45
(0.1539%)
54467.35 44633.85
Nifty 50 23045.25
(-0.1151%)
26277.35 21281.45
Nifty 100 23508.35
(-0.0954%)
27335.65 21934.80
BSE SmallCap 47136.37
(-0.4917%)
57827.69 40097.13
BSE Sensex 76171.08
(-0.1606%)
85978.25 70234.43
BSE MidCap 40760.39
(-0.4538%)
49701.15 37138.02
BSE 100 24024.31
(-0.1376%)
27762.24 22334.49

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Bharat Forge fixes record date for interim dividend

Bharat Forge has fixed 18 February 2025 as record date for interim dividend of Rs 2.50 per equity share f...

Feb 12, 2025 17:39
Shivalik Bimetal Controls fixes record date for interim dividend

Shivalik Bimetal Controls has fixed 20 February 2025 as record date for payment of interim dividend of Rs...

Feb 12, 2025 17:36
AVT Natural Products fixes record date for interim dividend

AVT Natural Products has fixed 20 February 2025 as record date for interim dividend of Rs 0.30 per share ...

Feb 12, 2025 17:35
Power Finance Corporation fixes record date for interim dividend

Power Finance Corporation has fixed 28 February 2025 as record date for the purpose of ascertaining the ...

Feb 12, 2025 15:38
Hindustan Aeronautics fixes record date for 1st interim dividend

Hindustan Aeronautics has fixed 18 February 2025 as record date for first interim dividend of Rs 25 per e...

Feb 12, 2025 15:35
SBI Cards & Payment Services fixes record date for interim dividend

SBI Cards & Payment Services has fixed 25 February 2025 as record date for interim dividend, if any, on e...

Feb 12, 2025 10:38

Explore ETF

Disclaimer

ICICI Securities Ltd.( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.